Rosario Lizio

This inventor holds 13 USPTO granted patents and 11 published patent applications, plus 12 CIPO patents and 11 EPO patents. Top assignees: Evonik Rohm Gmbh, Evonik Roehm Gmbh, Evonik Operations Gmbh. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosario Lizio. Retrieved from https://idiyas.com/inventor/rosario-lizio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 11)

% Patents Active = 76.9

CIPO Patents = 12 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 16)

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 91(Granted Patents)

Location History:

Rossdof, DE (2012)
Rossdorf, DE (2011 - 2013)
Dieburg, DE (2014 - 2023)

Company Filing History:

Evonik Operations Gmbh

patents

Years Active: 2011-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12350398 - Biodegradable bone glue (2025-07-08),

2. 11642436 - Biodegradable bone glue (2023-05-09),

3. 10537530 - Solid dosage forms comprising an enteric coating with accelerated drug release (2020-01-21),

4. 10294337 - Process for preparing poly(glycolide-co-lactide) copolymer microparticles (2019-05-21),

5. 10172807 - Nanoparticle (2019-01-08),

6. 9597293 - Solid dosage forms comprising an enteric coating with accelerated drug release (2017-03-21),

7. 9050256 - Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles (2015-06-09),

8. 8951558 - Aqueous carbonated medium containing an amino(meth)acrylate polymer or copolymer (2015-02-10),

9. 8765152 - Pharmaceutical or neutraceutical formulation (2014-07-01),

10. 8568778 - Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration (2013-10-29),

11. 8431157 - Partly neutralised anionic (meth) acrylate copolymer (2013-04-30),

12. 8273375 - Multiparticle pharmaceutical dosage form for a low-soluble active substances and method for producing said pharmaceutical dosage form (2012-09-25),

13. 7871643 - Pharmaceutical form having a two-layer separating layer (2011-01-18),

Title: Rosario Lizio: Innovating Biodegradable Solutions

Introduction

Rosario Lizio is a distinguished inventor based in Dieburg, Germany, who has made significant contributions to the field of biodegradable materials. With a portfolio that includes 13 patents, Lizio is focused on developing innovative solutions that enhance medical applications and tissue engineering.

Latest Patents

Among her latest inventions is a groundbreaking biodegradable bone glue. This invention is directed to bioresorbable polymers designed for use as bone and tissue adhesives. The innovation details the synthesis of bioresorbable polymeric molecules equipped with adhesive moieties, which can effectively glue and stabilize fractured bones and damaged tissues. Furthermore, this invention extends its applications to adhesive sealants for wound care, biodegradable ink for tissue engineering, 3D printing, and drug delivery platforms.

Career Highlights

Lizio's career features significant roles with prominent companies such as Evonik Röhm GmbH, where she honed her skills in polymer science and adhesive technologies. Her dedication to research has positioned her as a key figure in advancing biodegradable solutions in the medical field.

Collaborations

Throughout her career, Rosario has collaborated with notable professionals, including her coworkers Hans-Ulrich Petereit and Michael Damm. These partnerships have contributed to her innovation-driven approach and the successful implementation of her patented technologies.

Conclusion

In summary, Rosario Lizio stands out as a leading inventor in developing sustainable and innovative materials for medical applications. Her dedication to advancing biodegradable technologies through her patents reflects her commitment to improving healthcare outcomes and patient care.

Profile summary based on public USPTO records.